Summaries from the Clinical TMS Society Meeting in NYC 2014 - TMS Treatment of Major Depressive Disorder in a Severely Treatment Resistant Population

3:24:00 PM

Summaries from the Clinical TMS Society Meeting in NYC 2014


Transcranial Magenetic Stimulation for the Treatment of Major Depressive Disorder in a Severely Treatment Resistant Population

Oakdale TMS in New York retrospectively analyzed PHQ-9 scores from 44 patients and found that 56% of their patients responded to TMS while 35% remitted. Response was defined as a score reduction of at least 50%. Remission was defined as scores of <5 on the PHQ-9. All 44 patients were considered to have severe depression and on average had failed at least 10 medications prior to rTMS.

You Might Also Like

0 comments

Nashville Center for Hope & Healing
Neuroscience and TMS Treatment Center

Nashville Office
2125 Belcourt Ave Nashville, TN 37212
(615) 379-8600

Cool Springs Office
2001 Mallory Lane Ste 303 Franklin, TN 37067
(615) 224-9800